Pharmacokinetics and Safety of Ravidasvir and Danoprevir/r in Healthy Volunteers China
Clinical trial NCT03020134 · COMPLETED
Trial details
- NCT number
- NCT03020134
- Sponsor
- Ascletis Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-15
- Primary completion
- 2016-08-22
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.